Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 104,192 | 77,922 | 157,658 | 171,396 | 157,252 |
| Receivables | 294,667 | 367,577 | 242,020 | 219,735 | 214,018 |
| Inventories | 158,591 | 284,038 | 172,786 | 200,410 | 195,564 |
| TOTAL | $577,661 | $771,933 | $633,198 | $628,477 | $593,877 |
| Non-Current Assets | |||||
| PPE Net | 123,288 | 486,758 | 223,192 | 232,480 | 240,240 |
| Intangibles | 456,323 | 71,043 | 717,396 | 747,984 | 765,203 |
| Other Non-Current Assets | 63,626 | 12,155 | 75,368 | 92,167 | 96,640 |
| TOTAL | $643,237 | $569,956 | $1,015,956 | $1,072,631 | $1,102,083 |
| Total Assets | $1,220,898 | $1,341,889 | $1,649,154 | $1,701,108 | $1,695,960 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 17,859 | 89,171 | 17,836 | 17,824 | 17,813 |
| Accounts payable and accrued liabilities | 65,261 | 207,401 | 53,708 | 56,594 | 73,350 |
| Accrued Expenses | 268,676 | N/A | 252,494 | 266,084 | 231,691 |
| Other current liabilities | N/A | N/A | 25,000 | 18,746 | 18,538 |
| TOTAL | $351,796 | $296,883 | $349,038 | $359,248 | $341,392 |
| Non-Current Liabilities | |||||
| Long Term Debt | 771,216 | 1,355,274 | 767,935 | 766,460 | 765,101 |
| Other Non-Current Liabilities | -14,029 | 21,803 | 47,958 | 48,306 | 48,592 |
| TOTAL | $809,499 | $1,420,588 | $818,185 | $816,423 | $813,693 |
| Total Liabilities | $1,161,295 | $1,717,471 | $1,167,223 | $1,175,671 | $1,155,085 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,758 | 73,936 | 74,114 | 74,313 | 73,701 |
| Common Shares | 741 | N/A | 744 | 746 | 740 |
| Retained earnings | -503,004 | -382,785 | -71,376 | -22,007 | -1,590 |
| Other shareholders' equity | -108 | -1,359 | 311 | 415 | 642 |
| TOTAL | $59,603 | $-375,582 | $481,931 | $525,437 | $540,875 |
| Total Liabilities And Equity | $1,220,898 | $1,341,889 | $1,649,154 | $1,701,108 | $1,695,960 |